A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

August 17, 2016

Primary Completion Date

November 22, 2016

Study Completion Date

November 22, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Apremilast IR

Apremilast immediate release tablet

DRUG

Apremilast XL

Apremilast extended release formulation tablet

Trial Locations (2)

Covance-Daytona Beach, Daytona Beach

Covance Clinical Research Unit Inc, Madison